Pfizer to Acquire Obesity Drug Start-Up Metsera
Digest more
3hon MSN
Where Will Pfizer Be in 3 Years?
Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very ...
As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...
During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback